Literature DB >> 26038208

Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis.

Yasuhiro Nakamura1, Yuto Yamazaki1, Saulo J Felizola1, Kazue Ise1, Ryo Morimoto2, Fumitoshi Satoh2, Yoichi Arai3, Hironobu Sasano4.   

Abstract

Adrenocortical carcinoma (ACC) is a malignant neoplasm often associated with an aggressive biological behavior. The histologic differentiation between ACC and adrenocortical adenoma (ACA) is largely determined by employing the Weiss criteria, although this classification may not apply to all the cases. Additionally, various genomic features of ACC could be an auxiliary mode to establish the diagnosis of ACC. Most ACC cases are hormonally functional, and immunohistochemical analysis of steroidogenic enzymes has provided pivotal information as to the analysis of intratumoral production of corticosteroids. This article summarizes the current status of the histopathological diagnosis, molecular pathogenesis, and hormonal features of ACC.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adrenocortical carcinoma; Immunohistochemistry; Molecular pathology; Steroidogenesis; Weiss criteria

Mesh:

Substances:

Year:  2015        PMID: 26038208     DOI: 10.1016/j.ecl.2015.02.007

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  10 in total

1.  Construction of a risk signature for adrenocortical carcinoma using immune-related genes.

Authors:  Yang Fu; Shanshan Sun; Jianbin Bi; Chuize Kong
Journal:  Transl Androl Urol       Date:  2020-10

2.  Lung adenocarcinoma and adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1.

Authors:  Nobumasa Ohara; Masanori Kaneko; Masahiro Ikeda; Fumio Ishizaki; Kazuya Suzuki; Ryo Maruyama; Takeshi Komeyama; Kazuhiro Sato; Kenichi Togashi; Hiroyuki Usuda; Yuto Yamazaki; Hironobu Sasano; Kenzo Kaneko; Kyuzi Kamoi
Journal:  Respir Med Case Rep       Date:  2016-12-18

3.  ITRAQ-based proteomic analysis reveals possible target-related proteins in human adrenocortical adenomas.

Authors:  He Ma; Ranwei Li; Xin Di; Xin Jin; Yan Wang; Bingjie Lai; Cailian Shi; Mingxin Ji; Xinran Zhu; Ke Wang
Journal:  BMC Genomics       Date:  2019-08-16       Impact factor: 3.969

4.  Adrenocortical Carcinoma in Eight Children: A Report and Literature Review.

Authors:  Jing Li; Weiling Zhang; Huimin Hu; Yi Zhang; Yuan Wen; Dongsheng Huang
Journal:  Cancer Manag Res       Date:  2021-02-11       Impact factor: 3.989

Review 5.  The Role of Biomarkers in Adrenocortical Carcinoma: A Review of Current Evidence and Future Perspectives.

Authors:  Maja Mizdrak; Tina Tičinović Kurir; Joško Božić
Journal:  Biomedicines       Date:  2021-02-10

Review 6.  Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers.

Authors:  Yuling Cheng; Wei Kou; Dandan Zhu; Xinbo Yu; Yu Zhu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-01       Impact factor: 5.555

Review 7.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

8.  Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index.

Authors:  Yun Mi Choi; Hyemi Kwon; Min Ji Jeon; Tae-Yon Sung; Suck Joon Hong; Tae Yong Kim; Won Bae Kim; Young Kee Shong; Jae Lyun Lee; Dong Eun Song; Won Gu Kim
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

9.  Identification of hub genes and pathways in adrenocortical carcinoma by integrated bioinformatic analysis.

Authors:  Jinshuai Guo; Yinzhong Gu; Xiaoyu Ma; Lu Zhang; Huimin Li; Zhongyi Yan; Yali Han; Longxiang Xie; Xiangqian Guo
Journal:  J Cell Mol Med       Date:  2020-03-08       Impact factor: 5.310

Review 10.  Adrenocortical carcinoma: a literature review.

Authors:  Ammu Thampi; Ekta Shah; Ghada Elshimy; Ricardo Correa
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.